SWOG Southwest Oncology Group is a cooperative group of scientists and physicians. Southwest Oncology Group conducts clinical trials that are planned experiments designed to answer questions concerning the most appropriate treatment of future patients with a specific medical condition, in this case, cancer. Cancer trials support is important to the National Cancer Institute. Clinical trials are a part of science. Over 6,000 patients nationally are currently being registered to Southwest Oncology Group trials each year.
Breast cancer is the most common type of cancer in North American women.
It is a leading cause of cancer death, second only to lung cancer. Simply being a woman and getting older puts you at risk for breast cancer. Risk for developing breast cancer is individual. STAR, the study of tamoxifen and raloxifene, is a national research trial conducted by the National Surgical Adjuvant Breast and Bowel Project. In STAR, two drugs, tamoxifen and raloxifene, will be compared for their effectiveness in reducing the occurrence of breast cancer in postmenopausal women age 35 or older who are at increased risk for the disease.